Attrition of Patients on a Precision Oncology Trial: Analysis of the I‐PREDICT Experience

BACKGROUND: Precision oncology uses molecular profiling of tumors to identify biomarker‐tailored therapies for patients in the hope of improving outcomes. Typically, only a minority of patients receives evaluable matched treatment. This study explored the reasons for attrition on a precision medicin...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncologist
Prif Awduron: Bohan, Sandy S., Sicklick, Jason K., Kato, Shumei, Okamura, Ryosuke, Miller, Vincent A., Leyland‐Jones, Brian, Lippman, Scott M., Kurzrock, Razelle
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Inc. 2020
Pynciau:
Brief Communications
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7648352/
https://ncbi.nlm.nih.gov/pubmed/32949172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13532
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg